Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marc Ballas"'
Autor:
David C. Turner, Russ Wada, Helen Zhou, Xiaowei Wang, Rik deGreef, Chandni Valiathan, Lindsey Zhang, Nancy Zhang, Mita Kuchimanchi, Tai‐Tsang Chen, Marc Ballas, Sandra A. G. Visser
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 11, Pp 1751-1763 (2023)
Abstract Single‐arm cohorts/trials are often used in early phase oncology programs to support preliminary clinical activity assessments for investigational products, administered alone or in combination with standard of care (SOC) agents. Benchmark
Externí odkaz:
https://doaj.org/article/cff9183b44094e7ea64159028f35b5ab
Autor:
Agathe Dubuisson, Jean‐Eudes Fahrner, Anne‐Gaëlle Goubet, Safae Terrisse, Nicolas Voisin, Charles Bayard, Sebastien Lofek, Damien Drubay, Delphine Bredel, Séverine Mouraud, Sandrine Susini, Alexandria Cogdill, Lucas Rebuffet, Elise Ballot, Nicolas Jacquelot, Vincent Thomas de Montpreville, Odile Casiraghi, Camélia Radulescu, Sophie Ferlicot, David J Figueroa, Sapna Yadavilli, Jeremy D Waight, Marc Ballas, Axel Hoos, Thomas Condamine, Bastien Parier, Christophe Gaudillat, Bertrand Routy, François Ghiringhelli, Lisa Derosa, Ingrid Breuskin, Mathieu Rouanne, Fabrice André, Cédric Lebacle, Hervé Baumert, Marie Wislez, Elie Fadel, Isabelle Cremer, Laurence Albiges, Birgit Geoerger, Jean‐Yves Scoazec, Yohann Loriot, Guido Kroemer, Aurélien Marabelle, Mélodie Bonvalet, Laurence Zitvogel
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 1, Pp 1-11 (2020)
Abstract Decision making in immuno‐oncology is pivotal to adapt therapy to the tumor microenvironment (TME) of the patient among the numerous options of monoclonal antibodies or small molecules. Predicting the best combinatorial regimen remains an
Externí odkaz:
https://doaj.org/article/67054ca5ed634665a330aa95af51b5fb
Autor:
Hasan Alsaid, Shih-Hsun Cheng, Meixia Bi, Fang Xie, Mary Rambo, Tinamarie Skedzielewski, Bao Hoang, Sunish Mohanan, Debra Comroe, Andrew Gehman, Chih-Yang Hsu, Kamyar Farhangi, Hoang Tran, Valeriia Sherina, Minh Doan, M. Reid Groseclose, Christopher B. Hopson, Sara Brett, Ian A. Wilson, Andrew Nicholls, Marc Ballas, Jeremy D. Waight, Beat M. Jucker
Publikováno v:
Molecular Imaging and Biology. 25:528-540
Purpose The presence and functional competence of intratumoral CD8+ T cells is often a barometer for successful immunotherapeutic responses in cancer. Despite this understanding and the extensive number of clinical-stage immunotherapies focused on po
Autor:
David C. Turner, Russ Wada, Helen Zhou, Xiaowei Wang, Rik de Greef, Chandni Valiathan, Lindsey Zhang, Nancy Zhang, Mita Kuchimanchi, Tai‐Tsang Chen, Marc Ballas, Sandra A. G. Visser
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology.
Autor:
Gail J. Roboz, Karen Yee, Amit Verma, Gautam Borthakur, Adolfo de la Fuente Burguera, Guillermo Sanz, Helai P. Mohammad, Ryan G. Kruger, Natalie O. Karpinich, Geraldine Ferron-Brady, Andre Acusta, Heather Del Buono, Therese Collingwood, Marc Ballas, Arindam Dhar, Andrew H. Wei
Publikováno v:
Leukemia & Lymphoma. 63:463-467
Autor:
Clélia Coutzac, Jean Jouniaux, Aurore Vozy, Marc Ballas, Sara Brett, Sapna Yadavilli, Eric Angevin, Axel Hoos, Nathalie Chaput
Publikováno v:
Cancer Research. 79:2268-2268
Background: ICOS is a member of the CD28 superfamily mainly expressed on activated T cells. An up-regulation of ICOS+ T cells is observed in patients treated with ipilimumab. These findings prompt further studies examining the synergy between CTLA-4
PD-L1 expression in advanced NSCLC: Primary lesions versus metastatic sites and impact of sample age
Autor:
Kunyang Shi, Naiyer A. Rizvi, Marietta Scott, Anita Midha, Alan Sharpe, Jill Walker, Marina Chiara Garassino, Marc Ballas
Publikováno v:
Journal of Clinical Oncology. 34:3025-3025
3025Background: Determination of PD-L1 levels in tumors can help establish patient suitability for PD-1/PD-L1 targeted immunotherapies in NSCLC. Biopsies may be taken from different sites (primary ...
Autor:
Marc Ballas, Franco Muggia
Publikováno v:
Textbook of Medical Oncology, Fourth Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1097b52da43979ea779100e78b27d26
https://doi.org/10.3109/9780203092897-3
https://doi.org/10.3109/9780203092897-3
Autor:
Mikhail Shtivelband, David Planchard, Kelvin Shi, Marc Ballas, Ramy Ibrahim, Jean-Charles Soria
Publikováno v:
Journal of Clinical Oncology. 33:TPS8104-TPS8104
TPS8104 Background: M is a human IgG1 mAb that blocks programmed cell death ligand-1 (PD-L1) binding to programmed cell death-1 and CD-80 with high affinity and selectivity, and T is a selective hu...
Autor:
M.C. Garassino, Paul K. Stockman, D. Jayawardene, Johan Vansteenkiste, John D. Powderly, Marc Ballas, Jhanelle E. Gray, Naiyer A. Rizvi
Publikováno v:
Annals of Oncology. 26:i29